NeoGenomics (NEO) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 21, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote on key proposals before the meeting date.

Voting matters and shareholder proposals

• Election of nine directors is up for shareholder vote, with board recommending approval for all nominees.

• Advisory vote on executive compensation (say-on-pay) is included, with board recommending approval.

• Proposal to approve the Second Amendment of the 2023 Equity Incentive Plan is presented, with board support.

• Ratification of Deloitte & Touche LLP as independent registered public accounting firm is recommended.

Board of directors and corporate governance

• Nine director nominees are listed for election, reflecting board continuity and governance priorities.